BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38579174)

  • 41. GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
    Nambara S; Masuda T; Kobayashi Y; Sato K; Tobo T; Koike K; Noda M; Ogawa Y; Kuroda Y; Ito S; Eguchi H; Sugimachi K; Mimori K
    Cancer Sci; 2020 Feb; 111(2):343-355. PubMed ID: 31758608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-92a promotes tumorigenesis of colorectal cancer, a transcriptomic and functional based study.
    Chen E; Li Q; Wang H; Yang F; Min L; Yang J
    Biomed Pharmacother; 2018 Oct; 106():1370-1377. PubMed ID: 30119209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines.
    Garon EB; Finn RS; Hosmer W; Dering J; Ginther C; Adhami S; Kamranpour N; Pitts S; Desai A; Elashoff D; French T; Smith P; Slamon DJ
    Mol Cancer Ther; 2010 Jul; 9(7):1985-94. PubMed ID: 20587667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of tricellulin expression with poor colorectal cancer prognosis and metastasis.
    Zhang JX; Qin MB; Ye Z; Peng P; Li SM; Song Q; Lin L; Liu SQ; Xie LH; Zhu Y; Huang JA
    Oncol Rep; 2020 Nov; 44(5):2174-2184. PubMed ID: 33000262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased Expression of MPC2 Contributes to Aerobic Glycolysis and Colorectal Cancer Proliferation by Activating mTOR Pathway.
    Kuerbanjiang M; Gu L; Xu C; Xu WT; Wen S; Xue H; Xu Q
    J Immunol Res; 2021; 2021():6618837. PubMed ID: 33791391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non‑coding RNA ENST00000547547 inhibits cell proliferation, invasion and migration in colorectal cancer cells.
    Ai X; Lei Q; Shen X; Li J; Cen C; Xie G; Luo B; Zhu W; Hu G; Wu H; Chen M; Li X; Lin C
    Oncol Rep; 2019 Jan; 41(1):483-491. PubMed ID: 30542703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal Cancer proliferation.
    Ma W; Chen Y; Xiong W; Li W; Xu Z; Wang Y; Wei Z; Mou T; Wu Z; Cheng M; Zou Y; Zhu Y; Zhou W; Liu F; Geng Y
    J Exp Clin Cancer Res; 2021 Nov; 40(1):359. PubMed ID: 34781982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
    Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiproliferative Effects of Short-chain Fatty Acids on Human Colorectal Cancer Cells
    Ohara T; Mori T
    Anticancer Res; 2019 Sep; 39(9):4659-4666. PubMed ID: 31519564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of MAF1 homolog, negative regulator of RNA polymerase III in colorectal cancer progression.
    Hokonohara K; Nishida N; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Mizushima T; Doki Y; Mori M
    Int J Oncol; 2019 Mar; 54(3):1001-1009. PubMed ID: 30628658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
    Liang Z; Li X
    Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High expression of CREPT promotes tumor growth and is correlated with poor prognosis in colorectal cancer.
    Zheng G; Li W; Zuo B; Guo Z; Xi W; Wei M; Chen P; Wen W; Yang AG
    Biochem Biophys Res Commun; 2016 Nov; 480(3):436-442. PubMed ID: 27773816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High expression of partitioning defective 3-like protein is associated with malignancy in colorectal cancer.
    Li T; Liu X; Jiang Q; Lei X; Liu D
    Tumour Biol; 2017 Apr; 39(4):1010428317698393. PubMed ID: 28443499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA‑144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer.
    Jiang Y; Cai Y; Shao W; Li F; Guan Z; Zhou Y; Tang C; Feng S
    Oncol Rep; 2019 Apr; 41(4):2361-2370. PubMed ID: 30816505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.